Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -95.33% is 29% below its 5-year average of -73.81%, near the low end of its 5-year range (-121.80%–-30.65%).
17.18% above its 12-month average of -115.11%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -25.42%.
RETURN ON ASSETS (ROA)
-95.33%
RETURN ON ASSETS (ROA) AVG TTM
-115.11%
RETURN ON ASSETS (ROA) AVG 3Y
-93.94%
RETURN ON ASSETS (ROA) AVG 5Y
-73.81%
RETURN ON ASSETS (ROA) AVG 10Y
-81.55%
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+17.18%
CURRENT VS 3Y AVG
-1.48%
CURRENT VS 5Y AVG
-29.16%
CURRENT VS 10Y AVG
-16.90%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-29.10%
median of 631 covered companies
CURRENT VS SECTOR MEDIAN
-227.59%
vs the sector median at left
IceCure Medical Ltd
Market Cap
$3.28M
Return on Assets (ROA)
-95.33%
TTM Avg
-115.11%
3Y Avg
-93.94%
5Y Avg
-73.81%
Market Cap
$3.25M
Return on Assets (ROA)
-206.55%
TTM Avg
-205.58%
3Y Avg
-343.02%
5Y Avg
-343.02%
Market Cap
$3.27M
Return on Assets (ROA)
-111.26%
TTM Avg
-147.41%
3Y Avg
-127.90%
5Y Avg
-106.52%
Market Cap
$3.21M
Return on Assets (ROA)
55.30%
TTM Avg
-3307.76%
3Y Avg
-1681.95%
5Y Avg
-1351.74%
Market Cap
$3.40M
Return on Assets (ROA)
-8.01%
TTM Avg
-37.73%
3Y Avg
-92.58%
5Y Avg
-74.07%
Market Cap
$3.46M
Return on Assets (ROA)
-67.51%
TTM Avg
-41.84%
3Y Avg
-44.47%
5Y Avg
-41.13%
Market Cap
$3.49M
Return on Assets (ROA)
-19.43%
TTM Avg
-90.07%
3Y Avg
-138.72%
5Y Avg
-110.42%
Market Cap
$3.04M
Return on Assets (ROA)
-238.27%
TTM Avg
-211.11%
3Y Avg
-146.32%
5Y Avg
-173.65%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IceCure Medical Ltd (ICCM) | $3.28M | -95.33% | -115.11% | -93.94% | -73.81% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.25M | -206.55% | -205.58% | -343.02% | -343.02% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.27M | -111.26% | -147.41% | -127.90% | -106.52% |
| MBody AI Ltd. (MBAI)vs › | $3.21M | 55.30% | -3307.76% | -1681.95% | -1351.74% |
| Moolec Science S.A. (MLEC)vs › | $3.40M | -8.01% | -37.73% | -92.58% | -74.07% |
| Evogene Ltd. (EVGN)vs › | $3.46M | -67.51% | -41.84% | -44.47% | -41.13% |
| Eocene Ltd. (EOCN)vs › | $3.47M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -19.43% | -90.07% | -138.72% | -110.42% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | -238.27% | -211.11% | -146.32% | -173.65% |
| Nexalin Technology, Inc. (NXL)vs › | $3.58M | -299.21% | -178.76% | -127.09% | -697.98% |
ROA
-95.3%
ROE
-141.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -108.42% |
| 2024-12-31 | -121.80% |
| 2023-12-31 | -89.29% |
| 2022-12-31 | -56.24% |
| 2021-12-31 | -30.65% |
| 2020-12-31 | -36.43% |
| 2019-12-31 | -65.05% |
| 2018-12-31 | -67.26% |
| 2017-12-31 | -148.91% |
| 2016-12-31 | -98.71% |
| 2015-12-31 | -74.26% |
| 2014-12-31 | -142.59% |
| 2013-12-31 | 0.00% |
